Timothy Wright - 01 Apr 2022 Form 4 Insider Report for AGENUS INC (AGEN)

Reporting relationship: Director
Issuer ticker: AGEN
Reported as of: 01 Apr 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Apr 2022, 18:39:18 UTC
Prior SEC filing: 08 Feb 2022
Next SEC filing: 06 Jul 2022
Source filing: View source filing
Reporting owner signature: /s/Christine Klaskin as Attorney-in-Fact for Timothy R. Wright

Key filing fact

Timothy Wright filed Form 4 for AGENUS INC (AGEN) on 05 Apr 2022.

Key facts

This page summarizes Timothy Wright's Form 4 filing for AGENUS INC (AGEN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Apr 2022, 18:39.

Change

Previous filing in this sequence was filed on 08 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AGEN transaction Derivative

Deferred Stock Units

Award

Transaction value
Shares: +3,405
Change %: +2.5%
Price
Shares after: 138,301
Date: 01 Apr 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,405
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.

Footnote F2

Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.

Footnote F3

$2.753 per Deferred Stock Unit acquired on April 1, 2022. The price of each Deferred Stock Unit acquired prior to April 1, 2022 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan.